TECHNETIUM (99MTC) NANOCOLLOID

DRUG2 trials

Sponsors

Centre Oscar Lambret, Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Conditions

Intermediate-riskPatients with melanoma of the head/neck or the upper part of the trunkhigh risk endometrial canceroral malignancies or penile carcinoma who are scheduled for a sentinel node (SN) biopsy.

Phase 2

Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsy - NANOSCAN

RecruitingCTIS2024-519351-28-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichtingoral malignancies or penile carcinoma who are scheduled for a sentinel node (SN) biopsy., Patients with melanoma of the head/neck or the upper part of the trunk

Start: 2023-11-15Target: 29Updated: 2024-12-16

Phase 3

SENTIRAD-1502 - RANDOMIZED STUDY COMPARING SENTINEL NODE (SN) POLICY TO CURRENT FRENCH INITIAL STAGING PROTOCOLS IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE AND HIGH RISK OF RECURRENCE

Active, not recruitingCTIS2024-513079-42-00

Centre Oscar Lambrethigh risk endometrial cancer, Intermediate-risk

Start: 2015-11-19Target: 262Updated: 2026-01-15